Rein Therapeutics Inc.
RNTX
$1.16
$0.043.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.97M | -5.58M | -6.82M | -5.50M | -40.98M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 1.00K | -- | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.01M | 1.85M | 256.00K | 264.00K | 37.13M |
| Change in Net Operating Assets | -260.00K | 186.00K | 147.00K | -938.00K | -964.00K |
| Cash from Operations | -3.22M | -3.55M | -6.42M | -6.18M | -4.81M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -1.90M | 1.90M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.46M | 0.00 | 1.25M | 738.00K | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.85M | 0.00 | 3.47M | -- | 0.00 |
| Cash from Financing | 2.41M | 1.90M | 4.71M | 738.00K | 1.00K |
| Foreign Exchange rate Adjustments | -18.00K | -26.00K | -- | -- | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -833.00K | -1.67M | -1.71M | -5.44M | -4.81M |